Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,909
New position
Shares Held
56
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#223
of 239 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $8,088 across 7 Biotechnology names. NKTR ranks #1 (48.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTR |
Nektar Therapeutics
This page
|
56 | $3,909 | |
| 2 | VRDN |
Viridian Therapeutics, Inc.\DE
|
71 | $1,304 | |
| 3 | ASND |
Ascendis Pharma A/S
|
4 | $1,066 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
16 | $908 | |
| 5 | INVA |
Innoviva, Inc.
|
36 | $817 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
3 | $53 | |
| 7 | IMCR |
Immunocore Holdings plc
|
1 | $31 |
All Filings in NKTR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,909 | 56 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||